Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale SVP, Biologics Operations sold 48,912 shares at an average $2.55 ($124,576)
  4. 4 Grant or award SVP, Biologics Operations acquired 150,000 shares (grant or award)
  5. 4 Returned to the company Director returned 13,333 shares (to the company)
  6. 4 Open-market buy President and CEO bought 613 shares at $2.40 ($1,471)
  7. 4 Insider Changes in Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Grant or award President and CEO acquired 510,434 shares (grant or award)
  13. 4 Grant or award Exec. VC - Strategic Dev. acquired 510,434 shares (grant or award)
  14. 4 Grant or award Director acquired 100,000 shares (grant or award)
  15. 4 Grant or award Director acquired 100,000 shares (grant or award)
  16. 4 Grant or award Director acquired 100,000 shares (grant or award)
  17. 4 Open-market buy President and CEO bought 586 shares at $2.41 ($1,412)
  18. 4 Insider Changes in Ownership
  19. 4 Returned to the company SVP, Biologics Operations returned 54,036 shares (to the company)
  20. 4 Returned to the company SVP, Biologics Operations returned 25,804 shares (to the company)

Page 9 of 15 · 289 filings